Home Menopause Testing Market
Home Menopause Testing Market Study by FSH Test Kits, Perimenopause Blood Test Kits, Estrogen Testing, and Other Tests for Diagnostic Laboratories, Hospitals & Clinics, and Others From 2024 to 2034
Analysis of Home Menopause Testing Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Home Menopause Testing Market Outlook (2024 to 2034)
The global home menopause testing market is approximated to generate revenue worth US$ 18.1 billion in 2024 and has been thoroughly analyzed to increase at 7.1% CAGR to achieve a size of US$ 36.06 billion by 2034-end.
The need for tools that give information on a woman's hormonal status is growing as more women realize how important it is to comprehend and manage menopause symptoms. This trend is increasing due to educational programs and awareness campaigns.
As more people look for easy, discreet, and accessible ways to keep an eye on their health, at-home testing kits are becoming more popular. These kits are becoming more dependable due to the availability of more accurate and user-friendly hormone assays made possible by advancements in diagnostic technologies.
Improved usability and accuracy are attracting more customers seeking trustworthy information on their menopausal stage. The need for at-home menopausal testing is growing in response to women's increased proactivity in health management.
Early monitoring of hormonal changes and symptoms is driving women's growing interest in personalized medicine and preventative healthcare. Self-monitoring is supported with home menopausal tests, which also enable users to make requirement-based, well-informed healthcare decisions.
The North American region is estimated to account for 35.7% of the worldwide home menopause testing market share in 2024. This prominence is due to easy access to advanced medical technology and the presence of a strong at-home health test market in the region. The need for these tests is driven by North American women's growing desire for greater control over their health and menopausal treatment.
Based on test type, the demand for FSH test kits is forecasted to reach a worth of US$ 7.4 billion in 2024 due to the growing knowledge of menopause and reproductive health. As FSH plays an important role in deciding when menopause begins, it is crucial for women to monitor their fertility and comprehend their hormonal changes. FSH test kits provide a practical and easy approach to checking hormone levels at home as more women look to take charge of their health.
| Report Attribute | Detail |
|---|---|
| Home Menopause Testing Market Size (2024E) | US$ 18.1 Billion |
| Forecasted Market Value (2034F) | US$ 36.06 Billion |
| Global Market Growth Rate (2024 to 2034) | 7.1% CAGR |
| North America Market Share (2024E) | 35.7% |
| Western Europe Market Value (2024E) | US$ 3.8 Billion |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 9% CAGR |
| FSH Test Kits Segment Value (2034F) | US$ 15.22 Billion |
| Hot Flashes Segment Value (2034F) | US$ 21.13 Billion |
| Key Companies Profiled | Rapikit; Everlywell Inc.; Recombigen Laboratories Pvt. Ltd.; Mylan; PRIMA Lab SA; KÖRO?LU MEDICAL DEVICES; Verisana Laboratories; Wondfo; Hangzhou Singclean Medical Products Co. Ltd. |
The market is expected to witness growth owing to the growing elderly women population with an increase in menopausal hot flash symptoms, a rise in awareness regarding women’s health by several private and public organizations initiatives, and a different number of treatment introductions by major market players.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Home Menopause Testing?
The primary driving factors in the home menopause testing market are the growing incidence of menopausal hot flashes, increased awareness about menopause health, and a rising number of new pharmacological approvals for treatment.
Moreover, women aged 50 years and above experience more menopausal hot flashes than young women. This is expected to boost the market over the forecast period.
In addition, lifestyle changes, such as alcohol consumption, smoking, and other causing factors for menopausal hot flashes, are contributing to the increase in the number of women experiencing the condition.
Moreover, the companies and healthcare sector have augmented their awareness of menopausal hot flashes in terms of personal sanitation through different channels like social media regarding its treatment, which in turn is expected to boost the home menopause testing market.
Growing elderly women population with increase in menopausal hot flash symptoms, likely to boost Home Menopause Testing Sales
The growing elderly women population with an increase in menopausal hot flashes symptoms is expected to boost the global home menopause testing market. As per the study published in The Lancet Journal, in 2018, around 1 billion women will be above 50 years old in the coming 25 years and will be more probably to suffer from menopause or postmenopausal symptoms.
Moreover, above 73% of postmenopausal women have several hot flashes (vasomotor symptoms), which lead to sleep difficulties, fatigue, and reduced cognitive function reducing their quality of life and growing their use of medical resources. This needs special treatment for early diagnosis, which in turn increases the demand for the home menopause testing market.
US and Canada Home Menopause Testing Market Outlook
Because of the growing elderly women population with menopausal symptoms in the United States & Canada, the countries are expected to grow rapidly over the forecast years. The growth is also due to the increasing awareness about menopause health, the rising incidence of menopausal hot flashes, and the presence of a greater percentage of elder women in the complete population in this region.
As per the North American Menopause Society, around 75% of North American women suffer from hot flashes during perimenopause. Moreover, a study published in NCBI by Kimberly Peacock et al., in 2020 specified in the United States, around 1.3 million women become menopausal every year that starts between the ages of 51 and 52 years. Along with the same source, about 5% of women suffer from early menopause between the ages of 40 and 45 years.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Europe Demand Outlook for Home Menopause Testing
Europe would witness the highest growth after North America because of the rise in number of women experiencing menopausal hot flashes. For example, as per the article published by the National Center for Biotechnology Information (NCBI), it is projected that around 85% of post-menopausal women have suffered a menopause-associated symptom (hot flashes).
.Moreover, the advancement in new products and partnership activities of key market players is expected to drive the growth of the home menopause testing market in this region.
Who are the Key Manufacturers and Suppliers of Home Menopause Testing?
Some of the leading manufacturers and suppliers of Home Menopause Testing include
- Rapikit
- Everlywell Inc.
- Recombigen Laboratories Pvt. Ltd.
- Mylan
- PRIMA Lab SA
- KÖRO?LU MEDICAL DEVICES
- Verisana Laboratories
- Wondfo
- Hangzhou Singclean Medical Products Co.Ltd
The market is fragmented with the availability of different global and regional manufacturers. Acquisitions and mergers and expansion of product portfolios are the strategies adopted by these companies to increase market share. Key players in the home menopause testing market are focusing on digitally literate women to generate awareness about the issues associated with menopause via social media.
They are also focusing on increasing their efficiency in complementary and alternative medicine (CAM) for the management of menopause-related hot flashes.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Home Menopause Testing Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Segmentation of Home Menopause Testing Market Research
-
By Test Type :
- FSH Test Kits
- Perimenopause Blood Test Kits
- Estrogen Testings
- Thyroid Function Tests
-
By Indication :
- Hot flashes
- Osteoporosis
- Heart disease
- Stroke
-
By End User :
- Diagnostic Laboratories
- Hospitals & Clinics
- Home Care Settings
- Assisted Living Healthcare Facilities
- Research Laboratories & Institutes
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Test Type
- 6.2. Indication
- 6.3. End User
- 7. Global Market Analysis and Forecast, By Test Type
- 7.1. FSH Test Kit
- 7.2. Perimenopause Blood Test Kit
- 7.3. Estrogen Testing
- 7.4. Thyroid Function Test
- 8. Global Market Analysis and Forecast, By Indication
- 8.1. Hot Flashes
- 8.2. Osteoporosis
- 8.3. Heart Disease
- 8.4. Stroke
- 9. Global Market Analysis and Forecast, By End User
- 9.1. Diagnostic Laboratories
- 9.2. Hospitals & Clinics
- 9.3. Home Care Settings
- 9.4. Assisted Living Healthcare Facilities
- 9.5. Research Laboratories & Institutes
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Test Type, Indication, and End User for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Rapikit
- 20.2. Everlywell Inc.
- 20.3. Recombigen Laboratories Pvt. Ltd.
- 20.4. Mylan
- 20.5. PRIMA Lab SA
- 20.6. KÖRO?LU MEDICAL DEVICES
- 20.7. Verisana Laboratories
- 20.8. Wondfo
- 20.9. Hangzhou Singclean Medical Products Co. Ltd
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Bn Forecast by Region
Table 2: Global Market US$ Bn Forecast by Test Type
Table 3: Global Market US$ Bn Forecast by Indication
Table 4: Global Market US$ Bn Forecast by End User
Table 5: North America Market US$ Bn Forecast by Country
Table 6: North America Market US$ Bn Forecast by Test Type
Table 7: North America Market US$ Bn Forecast by Indication
Table 8: North America Market US$ Bn Forecast by End User
Table 9: Latin America Market US$ Bn Forecast by Country
Table 10: Latin America Market US$ Bn Forecast by Test Type
Table 11: Latin America Market US$ Bn Forecast by Indication
Table 12: Latin America Market US$ Bn Forecast by End User
Table 13: Western Europe Market US$ Bn Forecast by Country
Table 14: Western Europe Market US$ Bn Forecast by Test Type
Table 15: Western Europe Market US$ Bn Forecast by Indication
Table 16: Western Europe Market US$ Bn Forecast by End User
Table 17: Eastern Europe Market US$ Bn Forecast by Country
Table 18: Eastern Europe Market US$ Bn Forecast by Test Type
Table 19: Eastern Europe Market US$ Bn Forecast by Indication
Table 20: Eastern Europe Market US$ Bn Forecast by End User
Table 21: East Asia Market US$ Bn Forecast by Country
Table 22: East Asia Market US$ Bn Forecast by Test Type
Table 23: East Asia Market US$ Bn Forecast by Indication
Table 24: East Asia Market US$ Bn Forecast by End User
Table 25: South Asia & Pacific Market US$ Bn Forecast by Country
Table 26: South Asia & Pacific Market US$ Bn Forecast by Test Type
Table 27: South Asia & Pacific Market US$ Bn Forecast by Indication
Table 28: South Asia & Pacific Market US$ Bn Forecast by End User
Table 29: MEA Market US$ Bn Forecast by Country
Table 30: MEA Market US$ Bn Forecast by Test Type
Table 31: MEA Market US$ Bn Forecast by Indication
Table 32: MEA Market US$ Bn Forecast by End User
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Test Type
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Indication
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by End User
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Bn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth rate of the home menopause testing market?
The home menopause testing market is projected to expand at a CAGR of 7.1% from 2024 to 2034.
Why is the home menopause testing market witnessing major growth?
The market is growing with increasing cases of menopausal hot flash symptoms, and awareness about women's health through private and public sector initiatives.
Where will the home menopause testing market generate its major market share?
The market will generate its major share in North America because of the elderly women population with menopausal symptoms.
How much is the home menopause testing market analyzed to be worth in 2024?
The home menopause testing market is estimated to be worth US$ 18.1 billion in 2024.
Why home menopause testing market have high growth potential?
The market has high growth potential due to the surge growing elderly women population and the increase in menopausal hot flashes symptoms.
Home Menopause Testing Market